Hepatotoxicity of trovafloxacin – what is a future of the new promising fluoroquinolon? | CMAC

Hepatotoxicity of trovafloxacin – what is a future of the new promising fluoroquinolon?

Clinical Microbiology and Antimicrobial Chemotherapy. 1999; 1(1):66-67

​ Rafalskiy V.V.
Section
Antimicrobials
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 1999; 1(1):66-67
  • 1. Severe liver injury with Pfizer-s Trovan // SCRIP. - 1999. - No.2441. - P.20.
  • 2. Call to ban Trovan in US // SCRIP. - 1999. - No.2444. - P.13.
  • 3. Trovan restricted in US, suspension recommended in Europe // SCRIP. - 1999. - No.2446. - P.23.
  • 4. Trovan European suspension goes ahead // SCRIP. - 1999. - No.2447. - P.21. Trovafloxacin/alatrovafloxacin. In: Market Dynamics
Views
0 Abstract
0 PDF
0 Crossref citations
Shared